PATENT CLAIM ANALYSIS

Application Number: 16189461
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["540", "200000"]

Abstract:
[Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.

Claim (Index 16):
The method of  claim 14 , wherein the respiratory infection is one or more infections selected from the group consisting of pharyngitis, laryngitis, tonsillitis, acute bronchitis, pneumonia, and secondary infections of chronic respiratory diseases.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.33333
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14352141', '14741713', '10569062', '15578764', '15578758']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7827108443297572
- 35 USC 102 Novelty (BERT): 0.5413837929309137
- Combined Prediction Score: 0.7585781391898729
- Mean Citation Score: 355.84123
- Max Citation Score: 430.11282
- Similarity Product: 209.0309471719212

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test